Bone Support

Share Price

  • Contact Us
Follow
  • Global English Site
    • Global English Site
    • US site
    • Global Swedish Site
  • Bonesupport
    • Message from the CEO
    • Vision & Mission
    • Corporate Social Responsibility
    • History
    • Management
    • The Board
    • Our Partners
    • Careers
  • Products
    • CERAMENT® BONE VOID FILLER
    • CERAMENT® G
    • CERAMENT® V
  • Innovation
    • Current technology
    • Pipeline
    • Certify Clinical Trial
    • Fortify Clinical Trial
  • Medical Professionals
  • Investors
    • Financials
    • Financial Reports
    • Presentations
    • The Share
    • Shareholders
    • Analyst Coverage
    • Corporate Governance
    • Calendar
    • Q&A
    • Definitions
  • Patients
    • Bone Grafts
    • BONE DEFECTS CAUSED BY TRAUMA
    • BONE DEFECTS CAUSED BY BENIGN BONE TUMORS
    • BONE DEFECTS CAUSED BY HIP AND KNEE REVISIONS
  • Media
    • Press Releases
    • Publications and Resources
    • Multimedia
    • Events
  • Contact Us
  • Global English Site
  • US site
  • Global Swedish Site

  • Change in number of shares and votes in BONESUPPORT HOLDING AB (publ)

  • Fortify Clinical Trial

  • Certify Clinical Trial

  • Current technology

  • CERAMENT® V

  • CERAMENT® G

  • CERAMENT® BONE VOID FILLER

  • Issue and repurchase of series C shares for share saving program

  • BONESUPPORT’s FDA notification: Approval on DeNovo pathway for CERAMENT G will require additional data and clarifications

  • Change in number of shares and votes in BONESUPPORT HOLDING AB (publ)

1 2 3 … 22 »

©BONESUPPORT AB 2021. ALL RIGHTS RESERVED. CERAMENT and BONESUPPORT are registered Trademarks of BONESUPPORT AB.

  • Home
  • Contact Us
  • Privacy Policy
  • Cookie Policy